This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/4/797    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lupien, M. Articles by Mader, S. Search for Related Content PubMed PubMed Citation Articles by Lupien, M. Articles by Mader, S.

Raloxifene and ICI182,780 Increase Estrogen Receptor- Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12

Department of Medicine (M.L., S.M.), Division of Experimental Medicine, McGill University, Montreal, Québec, Canada H3A 1A3; Department of Chemistry (M.J., J.K.), University of Illinois, Urbana, Illinois 61801; Department of Biochemistry (E.H., K.H., A.A., G.D., G-A.P., S.M.) and Institute for Research in Immunology and Cancer (K.H., D.C.-W., S.M.), Université de Montréal, Montréal, Québec, Canada H3C 3J7; and Institut de Génétique et de Biologie Moléculaire et Cellulaire (C.L., J.-M.W., D.M.), 67 404 Illkirch Cédex, France

Address all correspondence and requests for reprints to: Sylvie Mader, Institute for Research in Immunology and Cancer, Université de Montréal, CP 6128 Succursale Centre-Ville, Montréal, Québec, Canada H3C 3J7. E-mail: sylvie.mader{at}umontreal.ca.

The basis for the differential repressive effects of antiestrogens on transactivation by estrogen receptor- (ER) remains incompletely understood. Here, we show that the full antiestrogen ICI182,780 and, to a lesser extent, the selective ER modulator raloxifene (Ral), induce accumulation of exogenous ER in a poorly soluble fraction in transiently transfected HepG2 or stably transfected MDA-MB231 cells and of endogenous receptor in MCF7 cells. ER remained nuclear in HepG2 cells treated with either compound. Replacement of selected hydrophobic residues of ER ligand-binding domain helix 12 (H12) enhanced receptor solubility in the presence of ICI182,780 or Ral. These mutations also increased transcriptional activity with Ral or ICI182,780 on reporter genes or on the endogenous estrogen target gene TFF1 in a manner requiring the integrity of the N-terminal AF-1 domain. The antiestrogen-specific effects of single mutations suggest that they affect receptor function by mechanisms other than a simple decrease in hydrophobicity of H12, possibly due to relief from local steric hindrance between these residues and the antiestrogen side chains. Fluorescence anisotropy experiments indicated an enhanced regional stabilization of mutant ligand-binding domains in the presence of antiestrogens. H12 mutations also prevent the increase in bioluminescence resonance energy transfer between ER monomers induced by Ral or ICI182,780 and increase intranuclear receptor mobility in correlation with transcriptional activity in the presence of these antiestrogens. Our data indicate that ICI182,780 and Ral locally alter the ER ligand binding structure via specific hydrophobic residues of H12 and decrease its transcriptional activity through tighter association with an insoluble nuclear structure.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα

Coregulators:   GRIP1

Ligands:   17β-Estradiol  |  4-Hydroxytamoxifen  |  Raloxifene  |  Fulvestrant

This article has been cited by other articles:

				B. M. Wittmann, A. Sherk, and D. P. McDonnell Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators Cancer Res., October 1, 2007; 67(19): 9549 - 9560. [Abstract] [Full Text] [PDF]